Athira Pharma Inc (NQ: ATHA )
3.320
+0.210
(+6.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Athira Pharma Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/02/image_5.jpg?width=1200&height=800&fit=crop)
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
January 02, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/06/aapharma_15.png?width=1200&height=800&fit=crop)
Athira Outlines Possible Comeback For Alzheimer's Candidate
September 06, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_854.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_17017.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/07/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image_7.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/07/image22.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/06/22/aapharma_2.png?width=1200&height=800&fit=crop)
Athira Pharma Shares Fall To 52-Week Low - Read Why
June 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_18766.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/05/biotech2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_16782.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/23/image12.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/23/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/22/mid-afternoon-market-update.jpg?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/june/mmc/mmc-stats-june-22.jpg?sfvrsn=7ca6af06_0)
![](https://cdn.benzinga.com/files/images/story/2022/06/22/mid-day-market-update.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/22/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/office-1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/08/pills.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/22/biotech3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/22/laboratory-ga19c290b1_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_8132.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_10984.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.